Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
Healthtrust
US Department of Justice
Queensland Health
Moodys
Fuji
Baxter
Deloitte

Generated: November 13, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: emtricitabine

« Back to Dashboard

emtricitabine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Gilead EMTRIVA emtricitabine CAPSULE;ORAL 021500 NDA Excella GmbH 46014-0601-1 30 CAPSULE in 1 BOTTLE, PLASTIC (46014-0601-1)
Gilead EMTRIVA emtricitabine CAPSULE;ORAL 021500 NDA State of Florida DOH Central Pharmacy 53808-0801-1 30 CAPSULE in 1 BLISTER PACK (53808-0801-1)
Gilead EMTRIVA emtricitabine CAPSULE;ORAL 021500 NDA Gilead Sciences, Inc. 61958-0601-1 30 CAPSULE in 1 BOTTLE, PLASTIC (61958-0601-1)
Gilead EMTRIVA emtricitabine SOLUTION;ORAL 021896 NDA Gilead Sciences, Inc. 61958-0602-1 1 BOTTLE, DISPENSING in 1 CARTON (61958-0602-1) > 170 mL in 1 BOTTLE, DISPENSING
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Federal Trade Commission
Queensland Health
Covington
Fuji
McKinsey
QuintilesIMS
Boehringer Ingelheim